RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Net income

BrightPath Biotherapeutics Co., Ltd.JP:4594

Market cap
¥4.5B
P/E ratio
-3.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 2025-1,151-1.45%
Mar 31, 2024-1,168-21.37%
Mar 31, 2023-1,486+0.10%
Mar 31, 2022-1,484-13.69%
Mar 31, 2021-1,720-7.44%
Mar 31, 2020-1,858-1.41%
Mar 31, 2019-1,884+19.48%
Mar 31, 2018-1,577+41.62%
Mar 31, 2017-1,114+11.99%
Mar 31, 2016-994+141.12%
Mar 31, 2015-412-2458.79%
Mar 31, 201417-91.96%
Mar 31, 2013218+680.97%
Mar 31, 201228

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)